TSX News -
Aptose Biosciences Files Proxy Statement, Announces Online Only Annual General Meeting
SAN DIEGO and TORONTO, April 24, 2020 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), […]
Digihost Postpones Reporting Due to Delays Caused by COVID-19 Pandemic
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI) announces that […]
Nordic American Tankers Ltd. (NYSE: NAT) – CNBC appearance in a strong tanker market with dividend in focus
Hamilton, Bermuda, April 24, 2020Dear Shareholders and Investors,NAT has more than 60,000 shareholders in the US and we receive many […]
Credicorp Announces Decisions Related to the Annual General Shareholders Meeting
Lima, April 24, 2020 (GLOBE NEWSWIRE) — Lima, April 23, 2020 – Credicorp Ltd. announces that the Board of Directors, in its session held […]
Algernon 獲得在韓國進行第 2 期 Ifenprodil 的 COVID-19 人類研究的監管和倫理批准
卑詩省溫哥華, April 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: [...]
Algernon的艾芬地尔第二阶段新冠肺炎人类研究在韩国获得监管和伦理审批
不列颠哥伦比亚省温哥华, April 24, 2020 (GLOBE NEWSWIRE) — 临床阶段药物开发企业Algernon Pharmaceuticals Inc.（CSE: AGN）（FRANKFURT: AGW）（OTCQB: [...]
Algernon reçoit une approbation réglementaire et éthique pour l’étude humaine de phase 2 sur l’ifenprodil dans le cadre du traitement du COVID-19 en Corée du Sud
VANCOUVER, Colombie-Britannique, 24 avr. 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE : AGN) (FRANCFORT : AGW) (OTCQB : AGNPF) (la « Société » ou […]
Algernon erhält in Südkorea Genehmigung der Regulierungsbehörde und Ethikkommission für seine Phase-II-Humanstudie zu Ifenprodil in der Behandlung von COVID-19
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das „Unternehmen“ oder […]
Algernon Menerima Kelulusan Kawal Selia dan Etika bagi Kajian Manusia COVID-19 Ifenprodil Fasa 2 di Korea Selatan
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“syarikat” atau “Algernon”) […]
アルジェノン、韓国で実施するCOVID-19治療薬としてのイフェンプロジル第II相臨床試験に規制当局による承認と倫理審査による承認を取得
ブリティッシュコロンビア州バンクーバー発, April 24, 2020 (GLOBE NEWSWIRE) — 臨床病期向け治療薬開発会社のアルジェノン製薬 (Algernon Pharmaceuticals Inc.) (CSE: AGN) (フランクフルト証券取引所: AGW) (OTCQB: AGNPF) (以下、「同社」または「アルジェノン」) [...]
